The investment is split in 170 million € for Nantong pharmaceutical base which will focus on the production of high quality Chinese medicine. In the inauguration ceremony, Merck also announced the establishment of life science center in Nantong with an investment of 80 million euros, specializing in the production of high purity inorganic salts and cell culture medium.
China Bio news release, November 7, 2016
Merck KGaA invests 250 million € in its Nantong plant.